Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 202   

Articles published

PFE 31.56 -0.03 (-0.09%)
price chart
Pfizer Inc.: Why is PFE Stock Going Nuts Today?
Pfizer Inc. (NYSE:PFE) stock is one of the biggest gainers from Donald Trump's surprise victory in the U.S. presidential race on speculation that his term will be less hostile to pharmaceutical and biotech companies.
Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?  Motley Fool
Pfizer Inc. (NYSE:PFE): Why Is PFE Stock Going Nuts Today?  Profit Confidential
Analysts Advise About Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) stock is presently standing at about $31.69 and lots of equity research firms seem to have a target price set on the stock.
Stock Worth Mentioning Today: Pfizer Inc. Rises A lot Today, Is Now One of ...  Frisco Fastball
Reg Filings: Fil LTD Trimmed Pfizer INC (PFE) Position by $118.39 Million  Chester News
Pfizer Announces Positive Top-Line Results from the Pivotal Comparative ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the pivotal REFLECTIONS B3271002 study, a comparative safety and efficacy study of PF-05280014 versus Herceptin� (trastuzumab), met its primary endpoint.
Pfizer Inc. (NYSE:PFE) & General Growth Properties Inc (NYSE:GGP) Worth ...  Money News
Pfizer's Herceptin biosimilar succeeds in key breast cancer study  Reuters UK
Analyst Opinions To Note: Southwestern Energy Company (NYSE:SWN), Pfizer Inc ...
Southwestern Energy Company (NYSE:SWN) remained bearish with a decrease -1.71% putting the price on the $12.08 per share in current trading session on 12/06/2016.
Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.
Pfizer can claim two things that Gilead can't: Revenue is rising and so are earnings (at least on a non-GAAP basis). The pharmaceutical company still has its own risks, though. Legacy established products continue to drag down overall growth. Sales are ...
Gilead Sciences, Inc. (NASDAQ:GILD), Pfizer Inc. (NYSE:PFE): Why Drug Stocks ...  Smаrt Stоck Nеws
Would Trump's Victory Benefit Valeant, Gilead, Pfizer?  TCC
BRIEF-Pfizer Inc, IBM announced a collaboration that will utilize IBM wats...
Dec 1 Twitter Inc appointed Keith Coleman, founder of startup Yes Inc, as head of its product team, the third executive to lead the division in less than a year.
analysts Estimates and Ratings: Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) will report its next earnings on Jan 31 - Feb 6 (Est.). The company reported the earnings of $0.61/Share in the last quarter where the estimated EPS by analysts was $0.62/share.
Analysts Upside For This Dividend Diamond: Pfizer Inc. (NYSE:PFE)
If investors are looking for a stable dividend stock with upside, Pfizer Inc. (NYSE:PFE) could be one that fits the bill. The stock currently provides a dividend yield of 3.79% for the Healthcare company.
what are Analysts report about: Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) will report its next earnings on Jan 31 - Feb 6 (Est.). The company reported the earnings of $0.61/Share in the last quarter where the estimated EPS by analysts was $0.62/share.
Stock's Buzzers: Canadian Natural Resources Limited (NYSE:CNQ), Pfizer ...  TRA
Two Stable Stocks: Pfizer Inc. (NYSE:PFE), Ambev S.A. (NYSE:ABEV)
The company announced its last quarter financial performance results on 11/01/2016. Pfizer Inc. (NYSE:PFE) belongs to NA sector that surged 0.29% in value when last trading session closed at $31.42.